Literature DB >> 6262993

Time dependent decreases of maternal canine virus antibodies in newborn pups.

W D Winters.   

Abstract

Levels of passively transferred maternal antibodies to three canine viruses, rabies virus (RV), canine distemper virus (CDV) and infectious canine hepatitis (ICH) virus, in serum specimens from 14 fetal pups and in serial serum specimens collected up to 45 days after whelping from 14 neonate pups were compared with levels of antibodies to these viruses in milk and sera collected concurrently from their respective dams. Radioimmunoassays using RV-, CDV- and ICH virus-specific antigens showed that sera from all fetal pups had detectable levels of antibodies to all three canine viruses and ICH neutralising antibodies were detected in sera from 10 of the 14 fetal pups. As the time after whelping increased, titres of RV-, CDV- and ICH virus antibodies measured by radioimmunoassay and ICH virus neutralising antibody tests in serially collected specimens of milk from dams rapidly decreased, while titres of the antibodies in serum specimens from newborn pups in their litters steadily decreased. Individual fetal and newborn pups with a high titre of antibody to one virus also had high titres to the other two viruses, although a wide range of titres was observed among pups in each of the litters studied. Markedly higher titres of antibody to all three viruses were observed in serially collected specimens of sera from dams than in sera from fetal and newborn pups in their litters. Results show that maternal RV, CDV and ICH virus antibodies are transferred from dams to pups in utero and by nursing. Levels of these maternal virus-specific antibodies in newborn pup sera decreased at similar rates as time after whelping increased.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262993     DOI: 10.1136/vr.108.14.295

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  7 in total

1.  DNA immunization of neonates induces immunity despite the presence of maternal antibody.

Authors:  E Manickan; Z Yu; B T Rouse
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

2.  Prevalence of phocine distemper virus specific antibodies: bracing for the next seal epizootic in north-western Europe.

Authors:  Rogier Bodewes; Danny Morick; Marco Wg van de Bildt; Nynke Osinga; Ana Rubio García; Guillermo J Sánchez Contreras; Saskia L Smits; Leslie Ap Reperant; Thijs Kuiken; Albert Dme Osterhaus
Journal:  Emerg Microbes Infect       Date:  2013-01-23       Impact factor: 7.163

3.  Investigation of an Imported Case of Rabies in a Juvenile Dog with Atypical Presentation.

Authors:  Nicholas Johnson; Alex Nunez; Denise A Marston; Graeme Harkess; Katja Voller; Trudy Goddard; Daniel Hicks; Lorraine M McElhinney; Anthony R Fooks
Journal:  Animals (Basel)       Date:  2011-11-18       Impact factor: 2.752

Review 4.  Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies.

Authors:  Stefan Niewiesk
Journal:  Front Immunol       Date:  2014-09-16       Impact factor: 7.561

5.  Use of hydrophilic extra-viral domain of canine distemper virus H protein for enzyme-linked immunosorbent assay development.

Authors:  Ki-hyun Cho; Jeongmi Kim; Hyun-ah Yoo; Dae-hee Kim; Seung-yong Park; Chang-seon Song; In-soo Choi; Joong-bok Lee
Journal:  J Vet Sci       Date:  2014-09-17       Impact factor: 1.672

6.  Recurring influenza B virus infections in seals.

Authors:  Rogier Bodewes; Danny Morick; Gerrie de Mutsert; Nynke Osinga; Theo Bestebroer; Stefan van der Vliet; Saskia L Smits; Thijs Kuiken; Guus F Rimmelzwaan; Ron A M Fouchier; Albert D M E Osterhaus
Journal:  Emerg Infect Dis       Date:  2013-03       Impact factor: 6.883

7.  Kinetics of maternal immunity against rabies in fox cubs (Vulpes vulpes).

Authors:  Thomas Müller; Thomas Selhorst; Peter Schuster; Ad Vos; Ulf Wenzel; Andreas Neubert
Journal:  BMC Infect Dis       Date:  2002-06-11       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.